ABT brings in $15M investment for market advancement

Producers of cyclotron and PET generator technologies ABT Molecular Imaging announced Oct. 20 that the company would be expanding into global markets with a $15 million boost in financing.

ABT, based in Knoxville, Tenn., will be gaining $10 million from SWK Holdings, a healthcare financing group, with an additional $5 million from a Series C cycle of funding.

“This infusion of capital is further affirmation of ABT’s unique proposition in the oncology market, and will enable us to access exciting new markets and develop our technology platform to better match significant untapped customer needs,” said ABT president and CEO Peter Kingma.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.